Medx Health Corp V.MDX

Alternate Symbol(s): MDXHF

Healthcare Medical Devices

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

TSXV:MDX - Post by User

Medx Health Corp > All good news.....

<< Previous

Bullboard Posts

Next >>

Comment by Insightful1on Nov 27, 2021 3:17am

145 Views

Post# 34171758

RE:RE:RE:RE:All good news.....

I dont know if you only watch MedX as a stock but there has been a subtantial meltdown in the overall microcap market. MedX has made a number of substantial announcements none of which are targeted to reluctant derms (whatever that means). Each one of the most recent announcments are with major distributors that will take MedX's technology to market.

To refresh your memory;

Nov 18 2021: MedX Health Corp. and Al Zahrawi Medical Supplies LLC Announce Distribution Agreement for Leading-Edge Teledermatology Screening Platform in United Arab Emirates

https://www.businesswire.com/news/home/20211118006346/en/MedX-Health-Corp.-and-Al-Zahrawi-Medical-Supplies-LLC-Announce-Distribution-Agreement-for-Leading-Edge-Teledermatology-Screening-Platform-in-United-Arab-Emirates

Nov 17 2021: MedX Health Corp. Announces Inaugural Clinical Trial of Leading-Edge Teledermatology Screening Platform in Turkey

https://www.businesswire.com/news/home/20211117006318/en/MedX-Health-Corp.-Announces-Inaugural-Clinical-Trial-of-Leading-Edge-Teledermatology-Screening-Platform-in-Turkey

Nov 16 2021: MedX Health Corp. and Makromed/Arhan Global Announce Distribution Agreement for Leading-Edge Teledermatology Screening Platform in Turkey

https://www.businesswire.com/news/home/20211116006363/en/MedX-Health-Corp.-and-MakromedArhan-Global-Announce-Distribution-Agreement-for-Leading-Edge-Teledermatology-Screening-Platform-in-Turkey

Sep 27 2021: MedX Health Corp. and Vitamed Biomedical s.r.l. to Pilot Leading-Edge Teledermatology Screening Platform in Italy

https://www.businesswire.com/news/home/20210927005176/en/MedX-Health-Corp.-and-Vitamed-Biomedical-s.r.l.-to-Pilot-Leading-Edge-Teledermatology-Screening-Platform-in-Italy

This is not as you state "the hardest way to market" it takes about 6 months of due diligence for any of these distribution partners to decide to add MedX to their portfolio but once the technology is proven the speed to market is quite rapid and MedX doesn't have to build a dedicated sales force. That is the beauty of their offering, once an install is in place MedX recieves recurring revenue everytime a patient has a consult on their system. I don't expect any real revenue breakthrough until the first quarter however as they populate the new locator map shareholders will get better data as to how many sites as well as how many consults have been performed. This will help shareholders understand the revenue model in real time. This is what the company said they were doing in a recent investor presentation.

Here is the new locator site;

https://medxhealth.com/find-a-location

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1